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Abstract
There is much interest in the mechanisms that regulate adult tissue homeostasis and their relationship to processes
governing foetal development. Mice deleted for the Wilms’ tumour gene, Wt1, lack kidneys, gonads, and spleen and die at
mid-gestation due to defective coronary vasculature. Wt1 is vital for maintaining the mesenchymal–epithelial balance in
these tissues and is required for the epithelial-to-mesenchyme transition (EMT) that generates coronary vascular
progenitors. Although Wt1 is only expressed in rare cell populations in adults including glomerular podocytes, 1% of bone
marrow cells, and mesothelium, we hypothesised that this might be important for homeostasis of adult tissues; hence, we
deleted the gene ubiquitously in young and adult mice. Within just a few days, the mice suffered glomerulosclerosis,
atrophy of the exocrine pancreas and spleen, severe reduction in bone and fat, and failure of erythropoiesis. FACS and
culture experiments showed that Wt1 has an intrinsic role in both haematopoietic and mesenchymal stem cell lineages and
suggest that defects within these contribute to the phenotypes we observe. We propose that glomerulosclerosis arises in
part through down regulation of nephrin, a known Wt1 target gene. Protein profiling in mutant serum showed that there
was no systemic inflammatory or nutritional response in the mutant mice. However, there was a dramatic reduction in
circulating IGF-1 levels, which is likely to contribute to the bone and fat phenotypes. The reduction of IGF-1 did not result
from a decrease in circulating GH, and there is no apparent pathology of the pituitary and adrenal glands. These findings 1)
suggest that Wt1 is a major regulator of the homeostasis of some adult tissues, through both local and systemic actions; 2)
highlight the differences between foetal and adult tissue regulation; 3) point to the importance of adult mesenchyme in
tissue turnover.
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Introduction
Although much is known about the mechanisms that govern
cellular differentiation during development, we know less about
the processes that regulate cell turnover and homeostasis in the
adult. Perhaps the exceptions to this rule are rapidly turning over
tissues such as intestine, skin and haematopoietic tissue. Recently it
has been shown that genes required for regulating differentiation
during foetal development may not be used in regulating turnover
of the same tissues in the adult [1,2].
Mutation of the Wilms tumour gene, WT1, in humans may lead
to the eponymous paediatric kidney cancer, glomerulosclerosis of
the kidney and gonadal dysgenesis, which can manifest as male to
female sex reversal [3]. During foetal development, Wt1 is
expressed in the kidney, gonads, spleen, the mesothelium which
surrounds most organs as well as ill-defined body mesenchyme.
Knockout mice lack kidneys, gonads, and spleen and the animals
die at mid-gestation through the lack of coronary vasculature
formation [4]. There are no apparent defects of the skeletal,
haematopoietic, digestive, or metabolic systems.
Recently we have shown that Wt1 is a key regulator of the
balance between the epithelial and mesenchymal states in a
number of developing organs. Whereas it is required for the
mesenchymal to epithelial transition (MET) underlying the
formation of kidney nephrons, in the heart it is essential for the
reverse process, the epithelial to mesenchyme transition (EMT)
required for the production of proliferating cardiovascular
progenitors from the epicardium (a mesothelium) [5]. In a similar
vein Wt1 expressing mesothelial cells in the intestine and lung
produce mesenchymal progenitors for vascular smooth muscle
[6,7]. Furthermore, very recent evidence proves that, in the
developing liver, Wt1 expressing mesothelial cells provide the
PLoS Genetics | www.plosgenetics.org 1 December 2011 | Volume 7 | Issue 12 | e1002404precursors for stellate cells [8,9,10]. Stellate cells in the liver and
the pancreas have aroused much interest through their ability to
regulate tissue fibrosis, via the production of cytokines [11,12].
They are also important for the progression of pancreatic cancer
[13].
In the adult, Wt1 is expressed in very few tissues in a small
percent of cells. These include the mesothelium surrounding a
number of visceral organs [14], the glomerular podocyte cells of
the kidney, Sertoli/granulosa cells in the testes/ovaries [15,16,17]
and 1% of bone marrow (BM) cells (with properties of restricted
haematopoietic progenitors) [18]. Nothern Blot analysis has shown
that Wt1 is also expressed in a variety of epithelial cells including
spleen, lung and heart. Our own data, including those provided in
this paper suggest that this mainly reflects expression in the
mesothelial lining of these tissues. We speculated that the
expression of Wt1 in these rare sites in the adult could have
functional significance, for the following reasons. Firstly, given the
importance of the mesothelium as a source of progenitor cells,
requiring Wt1 function during development, we hypothesised that
mesothelia might perform a similar function in the adult and this
might require Wt1.
Secondly, Wt1 is essential for the formation and maturation of
podocytes [19]. We hypothesised that continued expression of Wt1
in the adult would reflect a role in kidney maintenance.
Thirdly, WT1 is mutated or overexpressed in acute myeloid
leukaemia (AML) [20]. However, Wt1 is not required for foetal
haematopoiesis [21]. Given Wt1 expression in adult bone marrow
and association with leukaemia, we surmised that Wt1 might play
a role in adult haematopoiesis.
Finally, WT1 is expressed at high levels in most adult cancers
studied [22], though expression has not been detected in the
normal tissue counterparts. It has been proposed that WT1 might
be an oncogene in adult cancer in contrast to its function as a
tumour suppressor in paediatric kidney cancer [3]. As a prelude to
testing this, it was necessary first to determine whether the gene is
essential for normal development or maintenance of the epithelia
from which these tumours arise.
To address these propositions, we deleted the Wt1 gene
ubiquitously in adult mice. While our findings inform on these
issues, the results far exceeded our expectations. The range, severity,
and rapidity of the phenotypes observed were dramatic and
unexpectedandraisemajorquestionsaboutadulttissuehomeostasis.
Results
Tamoxifen-mediated deletion of Wt1
To enable inducible deletion of Wt1 in the adult, we generated
tamoxifen inducible Wt1 KOs by crossing CAGG promoter driven
Cre-ER
TM mice with our homozygous Wt1 conditional mice,
where the first exon of Wt1 is flanked by loxP sites [5]. Successful
Wt1 deletion was demonstrated by recombination PCR and the
depletion of Wt1 expression in mesothelia (Figure S1 and Figure
S2). Deletion of Wt1 in the mesothelium did not affect the integrity
of the tissue (Figure S3). The health status of the mutant animals
deteriorated quickly and all the mice had to be culled by 10 days
post-induction (p.i.). Prior to death, the mutant mice presented
dramatic phenotypes; they were less active and oedemic. Upon
dissection, fluid was sometimes found in the abdominal cavity and
in the subcutaneous tissues. Detailed gravimetric analysis showed
that there was a reduction in the spleen to body weight ratio as
well as in the heart to body weight ratio (Table 1). Subsequent
histological analysis of internal organs revealed pale kidneys,
severe spleen and pancreas atrophy, and deficiency of fat tissues.
For most tissues, mice treated at 3, 10, or 13 weeks of age
developed the same phenotypes. The only exception to this
involved fat, as we discuss in more detail later. Before considering
each phenotype, it is important to emphasise that not all tissues
showed overt signs of damage. For example, we observed no
obvious macroscopic changes to the lung, liver or intestine- three
tissues often involved in systemic inflammatory responses.
Furthermore, although there was a 30% reduction in the heart/
body weight ratio there was no obvious cardiovascular pathology
(Table 1).
Author Summary
It is important to understand the cellular and molecular
pathways that regulate the maintenance and turnover of
adult tissues. These processes often go awry in diseases
and are likely to deteriorate with ageing. Here we show
that removal of a single gene, the Wilms’ Tumour gene,
Wt1, in the adult mouse leads to the extremely rapid
deterioration of multiple tissues. Within 7–9 days after
gene removal kidneys fail, the pancreas and spleen suffer
severe atrophy, there is widespread loss of bone and body
fat, and red blood cells are no longer produced. Our
findings reveal the vulnerability of adult tissues, while
opening up avenues for dissecting the pathways control-
ling tissue turnover. Further experiments showed that the
tissue failure we observed is due both to local defects of
stem/progenitor cell activities and to significant changes in
the serum levels of some key master regulators. In
particular there is a dramatic reduction in the levels of
IGF-1, a key regulator of homeostasis and aging. Our
studies also show that the control of adult tissue turnover
may be different from that during foetal development.
These findings have important implications for under-
standing and treating common human diseases.
Table 1. Summary of the gravemetrics of adult mice deleted for Wt1.
Mature mice
Weight Spleen/BW % Kidney/BW % Heart/BW % Liver/BW % Testes/BW %
Mutant 20.07 0.26060.026 1.67360.085 0.50960.027 7.10360.55 0.64060.60
n=9 n=9 n=9 n=9 n=6
Control 20.87 0.58660.033 1.54860.053 0.71460.093 6.78060.34 0.79360.053
n=12 n=9 n=10 n=11 n=7
P-value 0.563 0.000
* 0.239 0.003
* 0.849 0.073
doi:10.1371/journal.pgen.1002404.t001
Wt1–A Major Regulator of Adult Homeostasis
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Wt1 is crucial for kidney development as the conventional Wt1-
null embryos suffer from renal agenesis [4]. Upon induction of
Wt1 deletion in our model, expression of Wt1 in the podocytes was
completely depleted (Figure 1B) and the mutant mice were shown
to have severe proteinuria (Table 2). H&E staining showed that
the tubules were filled with protein casts (Figure 1A, arrow). The
mutant kidneys had well developed glomerulopathy with cyto-
pathic changes in podocytes and parietal epithelium. There was
almost complete loss of synaptopodin and nephrin expression in
the podocytes in the mutant kidneys (Figure 1C and 1D). EM
studies showed that the foot processes of the podocytes were
completely lost in the mutant kidneys (Figure 1E, day 10 post-
injection). The development of the kidney phenotype in our model
was extremely rapid. Five days post-tamoxifen injection, H&E
stained kidney sections showed normal histology while podocyte
effacement started to appear (Figure 1F). At day 7 post-injection,
protein casts in the tubules were already present and the glomeruli
started showing signs of degeneration (Figure S4a). Finally, plasma
levels of urea and creatinine were normal at day 5 p.i., started to
rise at day 7 p.i., and were significantly elevated at day 10 p.i
(Table 2). In our model, mice that were heterozygous for the Wt1
conditional allele (CAGG-CreER
TM; Wt1
loxP/+) did not exhibit any
kidney abnormalities after tamoxifen-mediated deletion of Wt1.I n
addition, tamoxifen treated mice that were only positive for the
CAGG-CreER
TM allele and wild type for the Wt1 loxP sites (i.e.
CAGG-CreER
TM positive; Wt1
+/+) were also included as controls
and did not demonstrate any phenotypes. The kidney phenotype
in our model is similar to other nephrotic syndrome mice where
podocytes are damaged [23,24,25,26]. However, none of these
other mouse models presented any of the other phenotypes we
describe below apart from the kidney defects. Most importantly,
Wt1 has been deleted specifically in adult podocytes. These
animals develop glomeruloscelosis similar to that described here
but did not develop the other phenotypes we report below.
Furthermore, the mice survived well beyond the timeframe
reported here [27].
Wt1 is expressed at E9 in the urogenital ridge and subsequently
in the sex cords of the genital ridge in mice and it is a crucial factor
for gonad development and sex determination [28]. In adult mice,
Wt1 is expressed in Sertoli cells in the testes and granulosa cells in
the ovaries [15]. We observed a reduction in the size of the testes
and ovaries; however the difference was not statistically significant
(Table 1). None of the testis markers studied showed any difference
in expression patterns (Figure S5).
Deletion of Wt1 leads to an aberrant haematopoietic
system
Asplenia in the conventional Wt1-null mice correlates with
enhanced apoptosis in the primordial spleen cells [29]. In the adult
Wt1 KO model, the mutant spleen was much paler and smaller in
size compared with the control spleen (Figure 2A, arrow). There
was a reduction in the number of proliferating cells in the mutant
spleen; however the number of cells expressing an apoptotic
marker (active caspase 3) remained unchanged (Figure S8A–S8D).
The spleen to body weight ratio was reduced by 60% in the
mutants of both the young (Figure 2D, 3 week old, p-value=0.003;
8 controls and 5 mutants were analysed) and mature groups
(Figure 2D, p-value=0.000, 9 controls and 12 mutants were
analysed).
The mutant mice had diminished extramedullary haematopoi-
esis within the red pulp compartment while white pulp remained
largely unaffected (Figure 2B, 2C). FACS analysis showed an
almost complete absence of erythrocytes (Ter-119 positive) in the
mutant spleens (Figure 2E, 0.6960.17% in the mutant c.f.
55.763.9% in the control spleen, p-value=0.024; five controls
and three mutants were analysed) and in Wt1-mutant bone
marrow (Figure 2E, 7.363.1% in the mutant c.f. 30.364.0% in
the control bone marrow, p-value=0.025; five controls and three
mutants were analysed).
An intrinsic defect in the mutant haematopoietic system
Maturation of red blood cells requires erythropoietin (EPO)
[30], which is synthesised mainly in the kidney. Furthermore, Wt1
has been shown to transcriptionally activate the EPO gene [31]. To
determine whether the defect in erythropoiesis is intrinsic to the
haematopoietic system, we cultured the mutant bone marrow cells
in a methylcellulose-based system where a complete set of factors
for supporting haematopoietic differentiation is provided in the
medium. After two weeks in culture, despite the presence of all the
required growth factors, the Wt1-mutant bone marrow cells failed
to differentiate into the erythrocyte lineage, while the control bone
marrow cells, as expected, did form red blood cells (Figure 2F,
5.0%61.87% in the mutant compared with 31.3%69.6% in the
control; five controls and three mutants were analysed, p-
value=0.05).
To address whether this defect in erythropoiesis reflects a cell
autonomous role for Wt1 in haematopoiesis, we set out to
characterise the 1% of bone marrow cells that express Wt1. Using
the Wt1-GFP knockin mouse (Wt1
GFP/+), we FACS sorted GFP
positive cells from the bone marrow of Wt1
GFP/+ mice and
cultured them in a methylcellulose-based system. It has been
shown previously that some Wt1-expressing cells in the bone
marrow express markers characteristic of short-term haematopoi-
etic stem cells (Ter119
2CD45
+Mac-1
loc-kit
+Sca-1
+) [18] but the
differentiation potential of these cells was not investigated. Hence
we investigated the potential of these Wt1-GFP cells to
differentiate to different haematopoietic lineages in culture. First
we stained the GFP positive BM cells with a set of haematopoietic
stem cell markers (CD150, CD48, and CD244) [32] and showed
that approximately 50% of GFP positive BM cells were in the
population of oligolineage-restricted progenitors (CD150
2CD48
+-
CD244
2). Before culturing, no GFP-positive cells were positive for
Ter-119 or Cd11b and only a few percent of the cells expressed
CD45. After two weeks in culture, the GFP-positive cells were able
to form Ter119 (red blood cells), CD45 (white blood cells), and
CD11b (granulocytes) positive cells (Figure 2G). From this we can
conclude that the Wt1-expressing cells are oligolineage-restricted
progenitors.
We then set out to test if the reduction of erythrocytes reflected
a decrease in the number of erythrocyte progenitors (Pre CFU-E)
using the high resolution myeloerythroid progenitor cell staging
method described by Pronk et al [33]. Representative flow
cytometric profiles are shown in Figure 3. We saw a significant
reduction in the % of Pre CFU-E in the mutant spleen (Figure 3,
0.2760.06 in the controls and 0.0360.008 in the mutants, p-
value=0.001; 7 control and 8 mutant mice were analysed).
Erythrocyte progenitor cells branch from megakaryocyte-erythro-
cyte progenitors (PreMegE). Another progenitor that branches
from PreMegE is the Megakaryocyte progenitor (MkP) which
produces platelets. Both MkP and Pre MegE were reduced
significantly in the mutant spleen (Figure 3) However, the number
of platelets in the circulation was not affected (control platelet
number is 880.5689.9 K/mL and mutant platelet number is
817.56164 K/mL). Mutant mice did not show any obvious
bleeding tendencies. The half life of platelets is about 35 hours
[34]. Platelet deficiency may have developed if the mice had
survived longer.
Wt1–A Major Regulator of Adult Homeostasis
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We observed abnormalities of the growth plate in both the tibias
and femurs of Wt1-mutant mice. The vascular invasion zones were
irregular and anaemic (Figure 4A, indicated by arrow). The
proliferative zone chondrocytes of the mutant mice were irregular
with less surrounding territorial matrix than control mice
(Figure 4A). The inner (marrow) surface of the long bone from
the mutant mice was ragged compared with control mice
(Figure 4B, arrows), suggesting increased bone resorption. We
then analysed the bone architecture of femurs, tibias, and spine 9
days after induction of Wt1 deletion using mCT (Figure 4C). The
3D movie of the trabecular bone loss is shown in Videos S1 and
S2. Trabecular bone volume was reduced by 30% in the mutants
(Figure 4D), mostly due to a reduction in trabecular number and a
small reduction in trabecular thickness. Furthermore, trabecular
connectivity was also reduced. Taken together, these changes in
bone architecture would be expected to lead to a substantial
reduction in bone strength (Figure 4D). The bone loss observed
could be due to either reduced bone growth or increased bone
absorption. However, bone formation is a relatively slow process,
and in view of the rapidity of the phenotype observed here it
seemed that increased bone resorption was the more likely cause.
We therefore stained sections of the long bones for the osteoclast
marker TRAcP and observed dramatically increased numbers of
osteoclasts on the bone surface of the Wt1-mutant bones
(Figure 4E). To test if these bone phenotypes might reflect an
intrinsic role for Wt1 in the osteoclast and osteoblast lineages, we
harvested fresh bone marrow cells from the mutant mice, induced
Wt1 deletion by treating the bone marrow cells with 4-OH
tamoxifen for three days and cultured the cells in media
supplemented with M-CSF and RANKL to induce osteoclast
differentiation. Surprisingly and in contrast to the in vivo study,
mutant bone marrow cells in which Wt1 had been deleted by
tamoxifen treatment were less capable of forming osteoclasts in vitro
(Figure 4F, p-value=0.05 and 0.029 at 10 and 30 mg/ml of
RANKL respectively; three separate experiments were performed
each using bone marrow pooled from 2–3 control or mutant mice).
When we used a similar in vitro approach using culture medium
inducing osteoblastic differentiation, we observed that Wt1-mutant
osteoblasts had reduced bone differentiation ability as levels of the
osteoblast marker enzyme alkaline phosphatase were reduced
(Figure 4G, p-value=0.037; three separate experiments were
performed). These results suggest that Wt1 plays an intrinsic role
in both osteoclast and osteoblast differentiation, and that the loss
of Wt1 is likely to disturb bone homeostasis.
Fat reduction following Wt1 deletion
The Wt1-mutant mice also displayed reduction in the size of fat
pads. In addition to the abdominal fat pads which mainly
comprise white adipocytes, interscapular brown adipocytes were
also atrophic and had fewer lipid cytoplasmic vacuoles than
controls (Figure 5A–5J). Although the trend of fat loss was
consistent in mutant mice, the reduction of fat pad size seemed to
be more variable in the older group of animals (13 weeks,
Figure 5K, arrows). In some mutant animals, the reduction in the
size of fat pads was observed in both the interscapular and
abdominal fat pads, while in other mutants the lipid vacuole size
reduction was seen in the abdominal fat pads but not in the
interscapular fat pads. The weight of fat pads in the mutant mice
did not reflect their actual size because of the oedema (data not
shown), and we therefore analysed fat pad volume using whole
body mCT scans. Mice were scanned at the start (before tamoxifen
injection) and the end of the experiment (9 days after induction).
Results from the mCT scan confirmed the substantial fat loss in the
mutants (Figure S7, arrows). There was no difference in the
number of apoptotic and proliferating cells in the fat pads between
mutant and control mice. Histological analysis of the adipose
tissues showed that the reduction in the size of fat pads reflected a
decrease in the vacuole size of the adipose tissues, as seen in the
abdominal fat pads (Figure 5L–5M, p,0.05; three controls and
three mutant mice were analysed). Consistent with this loss of fat,
there was a significant reduction in the level of AP2 expression in
mutant abdominal fat pads (Figure 5N, p-value=0.05; three
controls and three mutants were analysed).
Wt1 expression in fat has not been reported previously.
However, here we show that Wt1 is expressed in the mesentery,
Figure 1. Severe kidney phenotype in the adult conditional Wt1 KOs. A, At day 10 post-injection, H&E staining of paraffin sections showing
accumulation of protein cast in the mutant kidney (right) c.f. control (left). B, Kidney sections stained with a Wt1-specific antibody in the mutant
kidney (right) c.f. control (left); scale bar, 20 mm. C, Immunostaining of a podocyte marker synaptopodin; scale bar, 10 mm. D, Immunostaining of
nephrin in the control and mutant kidney (right); scale bar, 10 mm. E, EM studies show the presence of foot process (arrows) of the podocytes in
control mice (left) while the foot process is completely abolished in the mutants (right) at day 10 postinjection. F, At day 5 post-injection, effacement
of foot process starts to show in the mutants c.f. the normal controls; scale bar, 2 mm.
doi:10.1371/journal.pgen.1002404.g001
Table 2. Urine and serum biochemistry analysis of adult mice deleted for Wt1.
N Urine protein (mg/dl) Serum urea (mmol/l) Serum Creatinine (mol/l) Serum albumin (g/l) Serum amylase (U/l)
Day 5 Control 4 561.81 9.6361.13 25.9861.78 560.7664.7
Mutant 3 4.660.26 8.161.56 22.462.55 597.3641.5
P-value 0.857 0.533 0.267 0.533
Day 7 Control 6 5.6260.88 11.8261.08 21.4262.23 427.3696.3
Mutant 5 11.0864.22 15.2563.51 Not detected 367634.6
P-value 0.021* 0.127 n/a 0.289
Day 10 Control 5 65.1615.2 6.6660.78 12.0860.76 25.8561.27 6486117
Mutant 3 1503.76137.3 30.1768.47 58.6651.33 15.460.57 3926172
P-value 0.05* 0.025* 0.064 0.083 0.165
doi:10.1371/journal.pgen.1002404.t002
Wt1–A Major Regulator of Adult Homeostasis
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levels in the abdominal fat pad nor in the interscapular brown
adipose tissue (Figure 5O, 5P). Given the fact that adipocytes and
osteoblasts have a common origin in the bone marrow, we
examined whether there was any alteration in the number of
adipocytes in the bone marrow. Labelling adipocytes using
AdipoRed, we found a reduction in the number of adipocytes in
the mutant bone marrow (Figure 5Q, p-value=0.021; four
controls and four mutants were analysed).
As adipocytes and osteoblasts arise from the stromal mesenchy-
mal population in the bone marrow, we speculated that Wt1 loss
might lead to a disturbance in this population which can be
quantified using an antibody to Stro-1. We did in fact find a
significant (five fold) increase in this population of cells following
Wt1 loss (Figure 4H, p-value=0.02; four controls and four
mutants were analysed).
Deletion of Wt1 leads to atrophy in the exocrine pancreas
Figure 6G–6J (arrows) shows the successful depletion of Wt1
expression in the pancreatic mesothelium. The pancreas from the
mutant mice was severely atrophied. H&E staining demonstrated
that there was a substantial amount of cell loss in the exocrine
tissues while the endocrine pancreas remained largely unaffected
(Figure 6A, 6B). Acini in the mutant pancreas were loosely packed
and acinar cells appeared atrophied and presented less eosino-
philic cytoplasmic staining, suggesting a reduced zymogen content.
Residual acinar epithelial cells were rounded and less cohesive
with neighbouring cells. Similar aberrant histology started to
appear at day 7 after Cre activation (Figure S4B). We saw an
increase in the number of apoptotic cells in the mutant pancreas
(Figure 6C, 6D) while the number of proliferating cells remained
unchanged (Figure 6E, 6F). Although the pathology of our model
shares many similarities to pancreatitis mouse models, there was
no elevation of serum amylase level in the Wt1-mutant mice
(Table 2). Given the severity of the pancreas phenotype, it is
surprising to see the lack of any elevation of serum amylase.
However, this probably reflects the short space of time between
the onset of the phenotype and death of the mice. Pancreatitis
involves inflammation of the pancreatic tissues and in Wt1-mutant
mice we observed a low-grade inflammation in much of the
pancreas and scattered foci of more severe active inflammation. In
the Wt1-mutant pancreas, the presence of infiltrating macrophages
was confirmed by staining with macrophage marker F4/80 (Figure
S6E, S6F); however, staining of CD11b, Gr1, and CD3 were
absent (data not shown). Both insulin and amylase expression were
normal in the mutant pancreas sections (Figure S6A–S6D).
To try to gain more insight into the origin of the pancreatic
phenotype, we examined more closely the cell types that express
Wt1 in the exocrine pancreas. Pancreatic stellate cells (PSCs) have
been implicated in pancreatitis and pancreatic cancer. We show
Wt1 is expressed in the mesothelial lining of the pancreas as well as
in PSCs. Desmin is a marker for PSCs [35]. The interstitial cells
that express Wt1 also express desmin, and this was demonstrated
in sectioned pancreata (Figure 6K–6M) and in cultured PSCs
(Figure 6N).
Serum protein profiling reveals no systemic inflammatory
or nutritional response but dramatic reduction in IGF-1
levels
One possible explanation for the dramatic and acute nature of
the phenotypes observed in these mice is a systemic inflammatory
response, even though analysis of the diseased pancreas did not
suggest this. Furthermore, even though the animals appeared to
show no signs of distress and their stomachs were full at 9–10
days, it is possible that the bone and fat defects were due to
nutritional deprivation. To assess these possibilities, we carried
out quantitative analysis of 40 cytokines and 38 adipokines in
mutant versus wildtype serum using antibody arrays. Perhaps
surprisingly, given the severity of the phenotypes there was no
statistically significant change in the levels of any inflammatory
cytokines (Figure 7A; three controls and three mutants were
analysed), arguing that the phenotypes were not due to a systemic
inflammatory response. As a positive control to test that the
arrays were working, we treated the mice with LPS and then
assayed cytokine levels. There was a 23 fold induction in MIP-2,
an 11 fold induction of JE, a 6 fold induction of KC, and a 3 fold
induction of TNFa (Figure 7B). These findings demonstrate that
the assays work and are able to measure an acute systemic
inflammatory response. Similarly, there was no indication of
nutritional deprivation. Following calorific restriction, there is
reported to be a 60–80% reduction in serum leptin levels [36,37],
a 65% reduction in TNFa [38], a 100% increase in AgRP/FIAF
[39], and a 75% increase in the levels of adiponectin [40]. We
saw no significant changes in any of these molecules (Table 3 and
Figure 7C), supporting the idea that the mice were not suffering
nutritional deprivation and, in turn, this was not causing any of
the phenotypes. However, we did observe a dramatic 85%
reduction in the levels of IGF-1 and 3.5 fold increase in the levels
of FGF21 (Figure 7C). This could in part account for the bone
and fat phenotypes respectively. To investigate if the reduction of
IGF-1 levels could due to global growth hormone deficiency, we
measured circulating growth hormone (GH) using ELISA. We
observed a slight elevation of GH levels in the mutant serum
(Figure 7J; three controls and five mutants were analysed, p-
value=0.025). Histology analysis showed absence of any
pathological abnormalities in the pituitary and adrenal glands
(Figure 7D–7I).
Discussion
The multiple organ disturbance observed in adult mice deleted
for Wt1 is striking, and, we believe, unprecedented in terms of
severity and rapidity of onset. There is perhaps no need to point
out that most of these phenotypes have relevance for diseases
common in adults, even though our starting point was a gene more
or less defined for its role in the development of several organs.
Our study shows that Wt1 plays a key role in regulating the
production or turnover of red blood cells, bone and fat in the
adult. Despite intensive analysis of Wt1-null foetuses, including
those surviving to 18 days gestation, no developmental defects in
these tissues were found previously [4,29]. Thus our study
Figure 2. Deletion of Wt1 leads to an aberrant haematopoietic system. A, Images of mutant spleen (arrow) compared with control spleen
(injected at 3 week old); scale bar, 10 mm. (B,C) H&E staining show depletion of the red pulp compartment in the mutant spleen (C, arrow) c.f. in the
control spleen (B; injected at 10 week old);scale bar, 400 mm. D, Analysis of the spleen to body weight ratio (control, black; mutant, white box). E,
FACS analysis of spleen and bone marrow cells with CD-45 APC(y-axis) and Ter-119 PE(x-axis, red circles). The percentage of CD45 and Ter119 positive
cells is summarised in the table. F, FACS analysis of Ter119-PE and CD45-APC on control and mutant bone marrow cells grown in a methylcelluose
based medium, where Wt1 is deleted in vitro by culturing with 4-OH tamoxifen (1 mM). G, FACS analysis of Ter119, CD45, and CD11b on FACS-sorted
GFP positive bone marrow cells (from Wt1-GFP knockin mice) before and after grown in a methylcellulose-based system.
doi:10.1371/journal.pgen.1002404.g002
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employ different or additional players compared to foetal
development. Wt1 is among a list of genes whose methylation
increases with age in a genome-wide CpG island methylation
profiling study [41]. Therefore Wt1 expression levels may well
decrease with age. It will be important to determine whether Wt1
levels in these key cell populations reduce during aging or under
different environmental influences. If so, this could contribute to
disease-related phenotypes described here.
Although there is much future work needed to elucidate the
mechanisms underlying these phenotypes, there are several
conclusions we can draw at present. Perhaps, surprisingly, we
could detect no significant changes in serum cytokine levels,
arguing that the phenotypes we observe are unlikely to be due to a
systemic inflammatory response, even though this is often
associated with damage to the tissues that are affected in the
Wt1 mutant mice. As we argue below, the phenotypes involving
the kidney and erythrocytes reflect an intrinsic function of Wt1 in
Figure 3. High-resolution fractionation of erythroid progenitors in mutant spleen. Spleen cells were stained with antibodies against Sca-1,
c-kit, CD41, CD150, FcgR, CD105, and a cocktail mixture of mature blood cell lineage markers (Lineage). Cells were also stained with 7-AAD and only
live cells are displayed. Representative flow cytometric profiles are illustrated. The percentage of MkP, Pro Ery+CFU-E, Pre MegE, and Pre CFU-E in
control and mutant spleens is listed.
doi:10.1371/journal.pgen.1002404.g003
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PLoS Genetics | www.plosgenetics.org 8 December 2011 | Volume 7 | Issue 12 | e1002404Figure 4. Deletion of Wt1 leads to rapid bone loss. A, H&E staining show defects in the Wt1-mutant growth plates (arrows; injected at 3 week
old). B, H&E sections of long bone from control and mutant mice (injected at 3 week old). C, uCT images of trabecular bone of femurs from mutant
(right) and control mice (left) injected at 10 weeks old. D, Bone histomorphometry analysis on tibia, femur, and spine. Values are expressed as % of
change from control mice (8 mutants and 8 control mice were analysed). BV/TV: percentage trabecular bone volume; Tb.Th: Trabecular thickness;
Tb.Sp: Trabecular spacing; Tb.N: Trabecular number; Conn.Dn: Connectivity density. *:p,0.05; **:p,0.01; ***:p,0.001. E, TRAcP staining (red)
showing osteoclasts in the bone section. F, Analysis of in vitro osteoclast formation ability from control and mutant bone marrow cells in the presence
of RANKL at various concentrations (10 and 30 mg/ml). G, Analysis of alkaline phosphatase activity in osteoblasts, differentiated from bone marrow
cells. H, FACS analysis of % of Stro-1 positive cells in control and mutant bone marrow.
doi:10.1371/journal.pgen.1002404.g004
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PLoS Genetics | www.plosgenetics.org 9 December 2011 | Volume 7 | Issue 12 | e1002404Figure 5. Fat reduction following Wt1 deletion. Skin pulps from control (A) and mutant (B) mice (injected at 3 week old); scale bar, 1 cm. (C,D)
Images of abdominal fat pads. (E,F) Images of interscapular brown adipose tissue; scale bar, 5 mm. H&E staining of the corresponding fat pads is
shown in G–J, respectively; scale bar, 25 mm. K, H&E sections of abdominal fat pads from mice injected at 13 week old (arrows indicate lipid vacuoles).
Box plot of lipid vacuole size measurement of adipocytes in the abdominal fat pads from the younger group of mice (L) and from the matured group
of mice (M). N, Quantitative PCR analysis of AP2 expression in the abdominal fat pads in control and mutant mice. O, Quantitative PCR analysis of
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loss of fat and bone is likely to be a combination of systemic and
local factors.
The phenotypes involving the haematopoietic system and bone,
have their origins wholly or partly within the bone marrow itself.
Wt1 is expressed in a restricted haematopoietic progenitor
relative level of Wt1 expression in different fat pads. P, RT-PCR showing Wt1 and 18s rRNA expression in fat pads. SC, subcutaneous; BAT, brown
adipose tissue (interscapular brown adipose tissue); RP, retroperitoneal; EPI, epididymal; MES, mesenteric; M15, murine embryonic mesonephros-
derived cell line (positive control for Wt1 expression). Q, FACS analysis of number of adipocytes positive for AdipoRed in control and mutant bone
marrow (p-value=0.018).
doi:10.1371/journal.pgen.1002404.g005
Figure 6. Deletion of Wt1 leads to atrophy in the exocrine pancreas. (A, B) H&E staining show massive atrophy in the exocrine pancreas.
Immunohistochemistry analysis show active caspase 3 (C,D; scale bar, 40 mm); Ki67 (E,F; scale bar, 100 mm) and Wt1-antibody (G,H). Nuclei are stained
with DAPI (blue); scale bar, 100 mm. Higher magnification images are shown in I&J scale bar, 20 mm. K, Double immunofluorescence staining of
pancreas sections with Wt1-antibody (green)and desmin antibody (red). Nuclei are stained with DAPI (blue); scale bar, 25 mm. Area circled in (K) is
shown in a higher magnification in L&M; scale bar,10 mm. N, Double immunofluorescence of Wt1(green) and desmin (red) in cultured PSCs; scale bar
50 mm.
doi:10.1371/journal.pgen.1002404.g006
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osteoclast production. This is consistent with the previous finding
that Wt1 expression is upregulated during early myeloid
differentiation (particularly in the common myeloid progenitors
and megakaryocyte-erythroid progenitors) [18]. In keeping with
this, we found the levels of PreMegE, MkP, and Pre CFU-E were
significantly decreased in mutant spleen, Given the association of
Wt1 with AML, we might have expected an imbalance in the
myeloid compartment. Preliminary analysis has not demonstrated
a reduction in the absolute number of monocytes and granulocytes
in the circulation of Wt1 mutant mice. However, this may have
only become evident if the mice had survived longer.
The bone loss in most part is likely to result from the increase in
osteoclasts that we observed in the bone marrow. Paradoxically,
mutant mice showed a reduction in osteoclast formation ability in
vitro. The bone marrow compartment in which we saw an increase
in the number of osteoclasts consists of a mixed population of cells.
The mesenchymal stromal cells and haemaatopoietic stem cells are
Figure 7. Cytokine, adipokine, and growth hormone analysis in control and mutant plasma. A, Cytokine profiling in control and mutant
plasma. B, Cytokine array performed using plasma from mouse treated with LPS. C, Results from adipokine array showing fold of difference in the
level of adipokines between mutant and control mouse plasma. D &E, H&E staining of adrenal glands (control=left, mutant=right; scale
bar=100 mm). F&G, H&E staining of pituitary glands; scale bar=500 mm. H&I, H&E staining of pituitary anterior lobes; scale bar=50 mm. J,
Measurement of growth hormone (GH) in mouse plasma using ELISA.
doi:10.1371/journal.pgen.1002404.g007
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crosstalk between these cell types [42,43]. Our in vitro osteoclast
formation cell culture system started with a restricted population of
cells (bone marrow stromal cells). The in vivo and in vitro difference
could be due to factor(s) that are present in the bone marrow but
absent in the in vitro culturing system.
However, we also found that Wt1 is required for osteoblast
synthesis in bone marrow culture pointing to a role in the
mesenchymal lineage. Consistent with this, our preliminary
experiments have shown that non-haematopoietic Wt1-GFP
positive cells from the bone marrow stroma are able to
differentiate to bone and fat (unpublished observations). Further-
more, we show here that Wt1 loss also leads to an increase in Stro1
positive stromal mesenchymal stem cells, which may explain partly
the disturbance in adipocyte and osteoblast production in the bone
marrow. Our serum protein analysis showed a dramatic reduction
of IGF-1 levels and this might be expected to contribute to the
bone loss phenotype. Interestingly, deletion of IGF-1 specifically in
the liver, the major source of synthesis, only leads to a 75%
reduction in circulating IGF-1 levels and there is no apparent
phenotype [44]. However, mice that are double homozygous
mutant for IGF-1 and the binding protein acid labile subunit
(ALS) [45] show an 85% reduction in IGF1- levels and a similar
degree of bone thinning to that seen in our Wt1 adult knockout
mice. Hence, it seems reasonable to conclude that the 85%
reduction of IGF-1 levels in our mutant mice is a major factor
behind the bone phenotype. In the Wt1 mutant mice, the IGF-1
levels are much lower than those observed when IGF-1 is deleted
specifically in the liver, so either Wt1 is required for IGF-1
expression in non-hepatocytes, or for factors that stabilise IGF-1 in
the serum. Growth hormone, produced by the pituitary gland, is a
major regulator of IGF-1 levels. One possibility was that the
reduction in IGF-1 level was due to defects in the pituitary axis
and downregulation of GH. However, we detected no pathological
abnormalities in the pituitary and adrenal glands, and if anything
GH levels were increased.
Obesity is a major health problem and there is considerable
topical interest in the factors that regulate fat levels. Loss of Wt1
not only leads to reduced adipocyte production in the bone
marrow but also to rapid systemic loss of fat, with dramatically
reduced vacuole size. There are several reasons why we believe
this fat loss is not due to under-nourishment. Fat vacuole reduction
was already apparent 7 days after tamoxifen injection, at which
time the health status of the animals was normal. Nine days post-
injection, the mutant mice still actively sought food and their
stomachs were full on autopsy. Importantly, there was no change
in the levels of circulating leptin, adiponectin, TNFa, and AgRP/
FIAF, all of which would be expected to change dramatically after
one or two days of calorific restriction. There was a reduction in
the level of lipocalin 2 in mutant serum (Figure 7C). Lipocalin 2 is
abundantly produced from adipocytes [46,47]. The reduction of
lipocalin 2 could be caused by the reduced volume of adipose
tissues in mutant mice. Taken together our findings provide
evidence that Wt1 may influence both the formation and
maintenance of adipocytes. The fat loss is extremely rapid and
given that Wt1 only appears to be expressed in a proportion of fat
pads affected, it seems likely that systemic factors might be
involved. We found that the levels of circulating FGF21 increased
by 3.5 fold in the mutant animals and this would be expected to
induce some fat loss [48].
The RT-PCR result showed that Wt1 expression was detected
in fat pads (Figure 5O). In preliminary experiments to address
whether this reflects expression in mature adipocytes or the
stromal vascular compartments, we digested and fractioned fat
tissues from the Wt1-GFP knockin mice into the floating mature
adipocyte layer and the stromal vascular fraction. The majority of
the GFP signal was seen in the stromal vascular fraction
(unpublished data). This supports the idea that systemic or local
paracrine factors dependent on Wt1 are regulating adipocyte
homeostasis.
The effect of Wt1 loss on bone and fat turnover is interesting in
the context of Wilms’ tumours. We and others have shown that the
15–20% subset of Wilms’ tumours arising through WT1 loss are
more likely to be stromal (mesenchymal) predominant and often
contain ectopic tissues, including bone, fat, cartilage and muscle
[49,50,51]. Taken together this and our new findings underline the
key role of the mesenchyme and Wt1 in tissue turnover and
maintenance.
With regard to the pancreatic atrophy, this does not appear to
be typical pancreatitis as there was no increase in serum a-
amylase. However, as discussed above, amylase level may have
increased if the mice had lived longer. Serum cytokine profiles
showed that there was no systemic inflammatory response in the
mutant mice. In line with this there was no observable pathology
in liver, lung and intestine, all tissues susceptible to inflammation.
It remains to be seen whether the severe pancreatic atrophy is due
to loss of Wt1 function within the tissue itself. We can exclude an
effect through loss of Wt1 function in the islet or acinar cells as
deletion of the gene specifically in these cell types using PDX1-Cre
did not lead to overt pathology in the pancreas or elsewhere (P.
Hohenstein, V. Brunton, M. Frame, O. Samson and N. Hastie
unpublished observations). One possibility is that the pancreatic
atrophy arises through activation of the sub-population of stellate
cells that express Wt1 although further study is required to
investigate this hypothesis. Activated stellate cells produce
cytokines [52] and we speculate that these may be responsible
for destroying the acinar cells. Given the published data on foetal
liver [8], the parallel between pancreatic and hepatic stellate cells,
and the role of Wt1 in generating vascular progenitors from the
epicardium by EMT [5], we hypothesise that a proportion of
pancreatic stellate cells arise from the mesothelium, via an EMT,
once more pointing to the role of this tissue as a source of
mesenchymal progenitor cells.
Despite the accumulating knowledge about the importance of
Wt1 at multiple stages of kidney development, the function of Wt1
in the podocytes of mature glomeruli has remained the subject of
some speculation. Even though children and adult mice with Wt1
mutations characteristic of Denys-Drash and Frasier syndrome
develop glomerulosclerosis, it was always possible that the damage
had its origin in utero, rather than reflecting a continued function
for Wt1 in the maintenance of the adult kidney. Our results
provide the first evidence that Wt1 is crucial for maintaining the
integrity of mature podocytes. Our model allowed us to test
whether the glomerulosclerosis we observed arises through
Table 3. Comparison of change of adipokine levels in fasting/
caloric restriction condition and adult mice deleted for Wt1.
Fasting/Caloric restriction Wt1 deletion
Leptin 60–80% reduction [36,37] No change
Adiponectin 75% increase [40] No change
TNF-a 65% reduction [38] No change
AgRP/FIAF 100% increase [39] No change
IGF-1 30% reduction [56,57] 85% reduction
doi:10.1371/journal.pgen.1002404.t003
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mature podocytes. We did not see major changes in proliferation
or apoptosis in the mutant glomeruli deleted for Wt1 (using
proliferation marker anti-phosph-histone H3 and apoptosis
marker active caspase 3, Figure S8E–S8H). However, we showed
that loss of Wt1 expression resulted in damage to the foot processes
of the podocytes therefore causing a morphological alteration.
Nephrin is necessary for the renal filtration barrier and is also a
known downstream target of Wt1 during kidney development
[53]. Consistent with this we found that nephrin expression levels
reduce dramatically after Wt1 deletion, indicating that the
transcriptional regulation of nephrin by Wt1 continues into adult
life. Here we show that Wt1, known to be a key regulator of
nephrogenesis, is also vital for the maintenance of adult glomerular
structure and function, something that has been the subject of
speculation but not proven until now.
Clearly these findings should be followed up using tissue specific
Cre lines. However, at present suitable Cre lines are not available
for several of the crucial lineages we wished to investigate,
including the mesothelium and mesenchymal stem cells. In the
mean time, we have been able to use cultures to show that several
of the phenotypes we observed are intrinsic to the bone marrow.
The results presented in this study open new avenues of research
into mesenchymal cell function in adult tissues. The cell types that
express Wt1 in adult tissues e.g. the hepatic and pancreatic stellate
cells and bone marrow progenitors are mesenchymal. The other
major cell types expressing Wt1, namely the podocytes and
mesothelia are considered epithelial, but are unusual in expressing
high levels of mesenchymal markers, such as vimentin. Given our
findings, it is interesting to speculate on the possible relationships
between the cell types expressing and requiring Wt1 in these
different tissues. Different reports have shown that stellate cells
may arise from the mesothelium and bone marrow [10,54]. Our
studies suggest that Wt1 may have a function in both stellate cells
and bone marrow mesenchymal stem cells. Stellate cells, like the
epicardially-derived cells requiring Wt1, synthesise retinoic acid.
One of the striking features of stellate cells is the presence of
vitamin A (retinoid) droplets and this becomes lost upon stellate
cell activation. In the epicardium we have shown that RALDH2
levels and RA are reduced when Wt1 is deleted and that RALDH2
is a direct transcriptional target of Wt1 [9]. We have shown that
Wt1 is required for the EMT that generates RA-synthesising
coronary vascular progenitors from the epicardium and it is
interesting that an EMT is required for activation of stellate cells.
It is also notable that stellate cells synthesise high levels of fat and it
will be interesting to see if the Wt1 expressing cells in fat have
similarities to stellate cells and mesenchymal bone marrow cells.
Finally our findings may also have implications for cancer
therapy. There is a growing number of studies developing anti-
WT1 immune therapy for common cancers predicated on the
belief that WT1 is expressed at high levels in cancers [20,55], but
very low levels in the normal adult. Our findings raise questions
about this approach as damage to these normal Wt1-expressing
tissues might have adverse effects.
Materials and Methods
Generation of Wt1-conditional knockout mice
Mice were housed and bred in animal facilities at the MRC
HGU and the University of Edinburgh. Animals were kept in
compliance with Home Office regulations. The Wt1-conditional
line was made in our group [5]. To obtain [CAGG-CreER
TM
positive, Wt1
loxP/loxP] and [CAGG-CreER
TM negative, Wt1
loxP/loxP]
transgenic mice, [CAGG-CreER
TM positive] males were mated with
Wt1
loxP/loxP females, and the resulting offspring intercrossed. Wt1-
GFP knockin mice used in this study were kindly provided by
Professor H Sugiyama [18].
Tamoxifen-induced Wt1 deletion in [CAGG-CreER
TM,
Wt1
loxP/loxP] mice
Cre recombinase was induced by intraperitoneal administration
of tamoxifen (4 mg/40 g body weight for 5 days; Sigma). All
animal work was carried out under the permission of license. To
delete Wt1 in vitro, cells were treated with 4-OH tamoxifen (1 mM,
Sigma) for three days.
Full methods are described in Text S1. Antibodies and primers
are listed in Tables S1 and S2.
Supporting Information
Figure S1 PCR testing for Cre-mediated recombination in
inducible Wt1-KO. Top panel: PCR bands show the Cre-me-
diated recombination in all the tissues tested in the mutant mice
(indicated by ‘recombination site’, CreER
TM+/2; Wt1
loxP/loxP).
The Cre-mediated recombination is not 100% as PCR bands
represent no-recombination are still found in the mutant tissues
(indicated by ‘lox site’). Lower panel: no recombination was
detected in the control mice (tamoxifen injected litter mates,
CreER
TM2/2; Wt1
loxP/loxP).
(PDF)
Figure S2 Immunohistochemistry analysis of depletion of Wt1
expression in tissues from the mutant mice. Images of sections
from mutant mice (CreER
TM2/2; Wt1
loxP/loxp) are at the right
column, and images from the control mice (litter mates,
CreER
TM2/2; Wt1
loxP/loxP) which have also been injected with
tamoxifen are at the left column. Using a Wt1-specific antibody,
Wt1 expression is detected in the mesothelial lining of organs
including pancreas, spleen, lung, and uterus (brown, indicated by
arrows). Wt1 expression is not detected in the corresponding
tissues from the mutant mice. Scale bars, 20 mm in the heart,
pancreas, and spleen. 100 mm in lung, and 40 mm in uterus.
(PDF)
Figure S3 Immunohistochemistry analysis indicate the intact-
ness of the mesothelium in the mutant mice. Images of sections
from the mutant mice are shown in the right column and images
from the control mice are shown in the left column. Mesothelium
lining of organs is detected using a cytokeratin antibody. Scale
bars, 20 mm in the heart, pancreas, and spleen. Scale bar, 100 mm
in the lung and kidney.
(PDF)
Figure S4 Characterisation of phenotypes in Wt1-KO mice at
day 7 post-injection. H&E staining of sections from Wt1-KO mice.
A, In the mutant kidney, protein casts are already visible. B,
Moderate level of atrophy is seen in the mutant pancreas. C, The
reduction in the size of fat vacuoles in the abdominal fat pad is
already evident in the mutant mice. D, There is a slight reduction
of the size of fat vacuoles in the brown fat pad from mutant mice;
scale bars, 50 mm.
(PDF)
Figure S5 Minor gonadal defects in Wt1-KO mice. A, H&E
staining show control (left) and mutant (right) testes. B, H&E
staining of ovaries from control (left) and mutant mice (right).
Follicles and corpora lutea are present in all mice but there was
less luteal tissue in the mutant ovaries. In addition, there were
fewer large, antral and atreic follicles in the mutant ovaries.
Although the size of the gonads appear to be smaller in the
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Partial depletion of Wt1 expression in the Sertoli cells in the
mutant testes (D) compared with the control (C). Wt1 staining in
the granulosa cells in the ovaries (E) and its complete absence in
the mutant (F). (G–I), Immunohistochemistry analysis of the
expression of Sdmg1 (marker for Sertoli cells), Plzf1 (marker for
spermatogonia), and Mvh (marker for spermatogonia, spermato-
cytes, and round spermatids) between control (left column) and
mutant (right column) testes; scale bar, 50 mm.
(PDF)
Figure S6 Immunohistochemistry analysis of markers in the
pancreas. Images of sections from the mutant mice are shown in
the right column and images from the control mice are shown in
the left column. A–D, Immunohistochemistry staining indicate
normal insulin and a-amylase expression in the mutant pancreas;
scale bar, 50 mm. E, F, Using a pan marker for macrophages (F4/
80), infiltrating macrophages are detected in the mutant pancreas;
scale bar, 40 mm.
(PDF)
Figure S7 Fat reduction in mutant Wt1-KO using mCT.
Representative transverse images taken from the mCT scanned mice
before and after tamoxifen injection. Control mice (CreER
TM2/2,
Wt1
loxP/loxP) used for fat analysis are the sexed matched littermates
of the mutant mice (CreER
TM+/2,W t 1
loxP/loxP). Light grey shades
indicate fat tissues which are present in both control and mutant
mice before tamoxifen injection (arrows). Darker shades indicate
soft tissues and black shades indicate skeletons. Gaps indicate
gastric gas trapped in the intestines of the animal. After 9 days of
tamoxifen injection, a reduction in the fat pads is noticed in the
mutant mice.
(PDF)
Figure S8 IHC staining of apotosis and proliferation markers in
Wt1-KO mice. A,B, IHC staining of active caspase-3 in control
(left) and mutant (right) spleen; scale bar=50 um. C,D, IHC
staining of phospho-histone H3 in control (left) and mutant spleen
(right); scale bar=100 um. E,F, IHC staining of active caspase-3
in control (left) and muatnt kidney (right); scale bar=50 um. G,H,
IHC staining of phospho-histone H3 in control (left) and mutant
kidney (right); scale bar=50 um. expression in the mutant
pancreas; scale bar, 50 mm.
(PDF)
Table S1 Antibodies and dilution factor.
(PDF)
Table S2 Sequences of primers and Roche Universal Probe
Library number used for Q-PCR.
(PDF)
Text S1 Supporting methods.
(DOC)
Video S1 Movie shows mCT scanned structures of trabecular
bone of femurs from tamoxifen-injected control mouse.
(MOV)
Video S2 Movie shows mCT scanned structures of trabecular
bone of femurs from tamoxifen-injected mutant mouse.
(MOV)
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